CSI Market
Sign In | Register

Lakeshore Biopharma Co Ltd (LSB) Annual Balance Sheets

Annual · GAAP · USD millions
Access LSB quarterly Balance Sheets →
The data below summarizes Lakeshore Biopharma Co Ltd's balance sheet position from to Mar 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Mar 31 2024) (Mar 31 2023)
Assets
Cash & cash equivalent3.94
Other Short-term Investments0.45
Cash & Short-term Investments3.00
Accounts receivable69.03
Other Receivables0.01
Notes Receivable, Current0.11
Inventories31.36
Other Current Assets10.53
Prepaid Expense And Other Assets Current0.63
Total Current Assets116.06
Equipment/Property/Plant Net101.03
Intangible Assets10.04
Tax Assets, Noncurrent7.80
Other Assets, Noncurrent0.00
Restricted Cash Current0.03
Advance To Suppliers Current0.00
Operating Lease Right Of Use Asset1.03
Deferred Income Tax Assets Net3.33
Total Assets188.47
Liabilities
Accounts Payable, Current AC6.83
Accrued Liabilities And Other Liabilities7.82
Short-term Debt DE153.80
Other Liabilities, Current44.81
Taxes Payable0.39
Total Current Liabilities113.65
Long-term debt57.04
Capital Lease and Other0.00
Total Long-term Debt57.04
Combined Long+Short Total Debt (filer-reported)57.04
Derivative Liability, Noncurrent DE0.47
Accrued Income Taxes, Noncurrent0.10
Other liabilities, Noncurrent2.14
Accrued Liabilities And Other Current Liabilities0.00
Operating Lease Liability Current0.73
Deferred Government Grants Current0.00
Operating Lease Liability Noncurrent0.25
Deferred Government Grants Non Current0.00
Total Liabilities119.60
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock408.52
Retained Earnings / Accumulated Deficit-331.76
Accumulated Other Comprehensive Income-7.89
Defined Benefit Plan and Other0.00
Other Equity-7.89
Common Stockholder's Equity68.87
Total Stockholder's Equity68.87
Liabilities & Stockholder's Equity188.47
4 historic quarters locked

Sign in to unlock the full Lakeshore Biopharma Co Ltd balance sheet history.

Sign In Create Free Account

About Lakeshore Biopharma Co Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-069880

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.